Updated: Novo Nordisk cans 2 more trials of IL-6 heart drug for futility
Who reported it (5)
- Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped fiercebiotech.com · 5d ago
- Novo's hopes for ziltivekimab dwindle as two heart failure studies stopped early firstwordpharma.com · 5d ago
- Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation STAT · 5d ago
- Novo scraps two more heart drug trials, further dimming growth beyond obesity Reuters · 5d ago
- Updated: Novo Nordisk cans 2 more trials of IL-6 heart drug for futility Endpoints News · 5d ago broke it first
🌍 Around the world
This story first appeared in 🇩🇪 German coverage — 4.5 hours before Newsylist detected it in English news.
Detected by matching proper nouns and figures that survive translation. Times reflect when each edition's coverage was first indexed.
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
Sam Altman: OpenAI won't go public this year as IPO now would come at an 'ill-advised moment'
OpenAI will not pursue an initial public offering in 2026, according to statements from Sam Altman.
More than 2 million sour candy bottles recalled over potentially deadly choking hazard
More than two million sour candy bottles face a nationwide recall due to a potentially deadly choking hazard.
Charity founder says he secretly gave FTX fraud figure Caroline Ellison a job
A 501c3 charity has secretly hired former Alameda Research CEO Caroline Ellison, testing the crypto sector's redemption culture.
Court Strikes Down Trump Order to Keep an Aging Coal-Burning Plant Running
A federal court has blocked an order to keep an aging Michigan coal plant running, delivering a blow to revival efforts.
Why Cheap Used Cars Are So Hard to Find
Affordable pre-owned vehicles are increasingly difficult to locate as buyers chase low-cost inventory.
IEA warns of ‘lost period’ in global oil demand
Global oil demand faces a lost period as escalating conflicts and supply gaps push refining systems to the limit.